Infosys Ltd

- The document does not mention any current or planned fundraising through debt or equity. - Infosys has strong cash generation, with consolidated cash and investments at $4.5 billion after returning over $4 billion to shareholders in FY26. - The company follows a disciplined capital allocation policy focused on dividends and shareholder returns. - There is no indication of plans for issuing new equity or raising debt in the near future. - Acquisition activity is cautious and strategic, focusing on fit and integration rather than aggressive expansion requiring external funding.

- Infosys has invested in AI talent, AI capabilities, and AI-related partnerships such as with OpenAI and Anthropic, reflecting a strategic focus on AI transformation. - Continued investments are being made under Project Maximus, including lean automation and value-based selling initiatives. - The company has made acquisitions in healthcare and insurance sectors to expand strategic presence, with further acquisitions considered cautiously based on strategic, cultural, and value fit. - Sales and marketing expenses increased by approximately 40 basis points to support growth and AI investments. - Capital allocation includes steady dividend payouts, with a proposed final dividend increase of 11.6% over last year. - No explicit mention of large-scale infrastructure capex, but investments focus on talent, technology, and strategic acquisitions to drive future growth.

- Infosys expects volumes to remain flat or marginally positive over the next 12 months, with potential for better volumes if the macro environment improves (Page 45). - The company has baked in a 2.25% organic growth guidance midpoint for FY27, slightly lower than FY26's 2.4%. Growth factors include strong AI service expansion and macroeconomic improvements, offset by deflation/compression in some segments (Pages 38, 39, 40). - Large deal signings were strong in the past year ($15 billion, 55% net new deals, 28% YoY growth), indicating robust pipeline but some slower decision-making observed recently (Page 40). - AI-driven services contribute to growth but also cause deflationary pressures; overall, compression is managed alongside growth in AI and new services (Pages 38, 39, 45). - Acquisitions expected to add to growth but only partially factored in current guidance (Page 22). - Onsite mix compression and specific client ramp-downs (~1% impact) may temper volume-driven growth (Pages 38, 39, 45).

- FY27 revenue growth guidance is 1.5% to 3.5% in constant currency terms, reflecting a cautious but positive outlook amid macro uncertainties. - Operating margin guidance for FY27 is stable at 20% to 22%, factoring in wage hikes, productivity pass-throughs, AI investments, and acquisition impacts. - Acquisitions like Stratus are partially baked in (~25 bps contribution), while Optimum Healthcare and Versent JV are pending closure and not included yet. - Earnings per share (EPS) grew 11% for FY26; future EPS likely to benefit from margin stability and controlled costs. - Growth drivers include strong AI services demand, large deal pipelines, and expansions in Financial Services, Energy, and Utilities sectors. - Competitive intensity and productivity improvements result in some margin compression due to pricing pressure. - Focus on investments in AI talent and partnerships implies potential medium-term growth acceleration.

- Infosys signed $15 billion worth of large deals in the last fiscal year, spread across 96 deals. - Approximately 55% of these deals ($8.25 billion approx.) are net new business. - This represents a strong 28% year-on-year growth in large deal signings. - The pipeline for new deals is described as very good by management. - Despite some slower decision-making observed in March, there was no significant impact on large deal sign-ups. - Acquisitions announced last fiscal are expected to contribute around 200 to 225 basis points of growth in FY27, not yet factored into guidance. - Regulatory processes are ongoing for acquisitions such as Versent, which could impact timing. - Overall, Infosys expresses confidence in a strong deal pipeline and healthy demand environment.